Venus Remedies share news, announcements and annual reports
NSE: VENUSREMBSE: 526953Pharmaceuticals & BiotechnologySmall Cap
Venus Remedies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995 on BSE, Dec 2006 on NSE
Last close ₹1,238.60down ₹50.70 (3.93%)BSE ₹1,231.75
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,289.30.
30 Oct: open ₹1,290.00, high ₹1,319.00, low ₹1,225.10
52-week range of traded prices to 30 Oct 2026
₹432.10Low, 31 Oct 2025₹2,044.30High, 29 Jun 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,656 Cr1,337th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.35
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.81%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 48,127
Venus Remedies share news and announcements
697 announcements, routine notices left out, newest first. Page 12 of 14.
Feb 2012
27 Feb · Business
Board of Directors of the Company at its meeting held on February 27, 2012 inter alia approved allotment of 6,00,000 equity shares of Rs.10 each to promoter group company pursuant to conversion of warrants fully convertible into equity shares.20 Feb · Board meeting
To inter alia consider and approve issue and allotment of equity shares on conversion of fully convertible warrants to promoter group company on a preferential basis.
Jan 2012
16 Jan · Board meeting
To consider interalia Unaudited Financial Results (Provisional) for the quarter ended December 31, 2011 and to consider any other item with the permission of Chair.
Dec 2011
21 Dec · Board meeting
Board of Directors in its meeting held on December 21, 2011 has inter alia issued and allotted 17,00,000 fully convertible warrants on a preferential basis to Sunev Pharma Solutions Ltd., a promoter group Company.12 Dec · Board meeting
To consider inter alia allotment of 17,00,000 warrants fully convertible into equity shares to promoter group company on a preferential basis and any other item with the permission of chair.
Nov 2011
Oct 2011
17 Oct · Board meeting
To consider interalia Unaudited Financial Results (Provisional) for the quarter ended September 30, 2011 and to consider any other item with the permission of chair.
Sep 2011
Aug 2011
24 Aug · Board meeting
Board of Directors have in it's meeting held on August 24, 2011 inter alia approved : (1) Issue of fully convertible warrants on a preferential basis to Sunev Pharma Solutions Ltd., a promoter group company upto 5% of the total capital in a financial Year in accordance with SEBI (Substantial Acquisitions and Takeovers) Regulations, 1997. The same is also subject to applicable provisions of SEBI/Companies Act and approval of shareholders at the forthcoming Annual General Meeting; (2) Allotment of 12894 equity shares pursuant to request of FCCB holders for partly conversion of Foreign Currency Convertible Bonds at Conversion price of Rs. 364/-. The same is also subject to applicable provisions of SEBI/Companies Act and approval of shareholders at the forthcoming Annual General Meeting.16 Aug · Board meeting
To inter alia consider and approve : (1) Issue of fully convertible warrants to promoters/persons acting in concert on a preferential basis subject to approval of the general meeting; (2) Allotment of equity shares pursuant to request of FCCB holders for partly conversion of Foreign Currency Convertible Bonds; (3) Any other item with the permission of Chair.
Jul 2011
26 Jul · Meeting
Register of Members and Share Transfer Books shall remain closed from September 25, 2011 to September 30, 2011 (both days inclusive) for the purpose of Annual General Meeting and for the purpose of determining of entitlement to dividend. The Annual General Meeting of the Company will be held on September 30, 2011.26 Jul · Dividend
Board of Directors of the Company at its meeting held on July 26, 2011, recommended a dividend @ of 30% i.e. Rs. 3/- per share for the financial year ended March 31, 2011 subject to approval of the same by shareholders at the Annual General Meeting.26 Jul · Results
26 Jul · Results
18 Jul · Board meeting
To inter alia consider and approve : (1) Unaudited Financial Results (Provisional) for the quarter ended June 30, 2011; (2) Annual Accounts of the Company for the year ended March 31, 2011; (3) Recommendation of dividend for the year 2010-2011; (4) Fix the Date of Annual General Meeting; (5) Any other business with the permission of the Chair.
May 2011
3 May · Management
Ms. Neha Kodan, Company Secretary has been appointed as Compliance Officer w.e.f. April 11, 2011 as Ms. Nidhi Singla, Company Secretary has resigned from the Company.
Apr 2011
30 Apr · Results
20 Apr · Board meeting
To consider inter alia Unaudited Financial Results (Provisional) for the quarter ended March 31, 2011.
Mar 2011
30 Mar · Board meeting
Board of Directors have in it's meeting held on March 30, 2011 inter alia approved allotment of 6,00,000 equity shares of Rs. 10 each to promoter group company pursuant to conversion of warrants fully convertible into equity shares.21 Mar · Board meeting
To inter alia consider and approve allotment of 6,00,000 equity shares of Rs. 10 each to promoter group company pursuant to conversion of warrants fully convertible into equity shares.
Feb 2011
Jan 2011
17 Jan · Board meeting
To inter alia consider and approve Unaudited Financial Results (Provisional) for the quarter ended December 31, 2010.13 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 12, 2011 : (1) Approved increase in the borrowing limit upto Rs.500 crores over and above paid share capital and free reserve of the company under section 293(1) (d) of Companies Act, 1956 and also approved the increase in limits interalia for creation of charge/mortgage, etc., over and above paid share capital and free reserve of the company under section 293(1) (a) subject to the approval of shareholder's meeting. (2) Also approved calling an Extra ordinary General meeting for considering the above said proposal.
Dec 2010
20 Dec · Business
Board of Directors have in it's meeting held on December 18, 2010 has inter alia approved allotment of 37,137 equity shares of Rs. 10/- each pursuant to request for partly conversion of Foreign Currency Convertible Bonds by FCCB holders, out of US$ 5 million bonds rollover till 2015.9 Dec · Board meeting
To consider allotment of 37,137 equity shares pursuant to request for partly conversion of Foreign Currency Convertible Bonds by FCCB holders, out 5 million bonds rollover till 2015.
Nov 2010
Oct 2010
18 Oct · Business
Board of Directors at its meeting held on October 15, 2010 transacted the following business: 1) Allotted 12,00,000 warrants fully convertible into equity shares to Sunev Pharma Solutions Limited a promoter group company on preferential basis.7 Oct · Board meeting
To inter alia consider and approve Unaudited Financial Results (Provisional) for the quarter ended September 30, 2010 and allotment of 12,00,000 warrants fully convertible into equity shares to promoter group Company on a Preferential basis.
Sep 2010